Mother	Child
Option A	If CD4 cell count ≤350 cells/μL, start triple antiretrovirals at diagnosis and continue for life. If CD4 cell count >350 cells/μL start antepartum zidovudine at 14 weeks' gestation. Intrapartum: standard dose nevirapine, zidovudine and lamivudine; postpartum: zidovudine and lamivudine for 7 days		Standard dose nevirapine daily for 6 weeks in non-breastfed infants or with mothers on antiretroviral therapy, or until 1 week after all breastfeeding has stopped
Option B	All HIV-infected pregnant women start triple antiretrovirals irrespective of CD4 cell count. If CD4 cell count ≤350 cells/μL, continue triple ART for life. If CD4 cell count >350 cells/μL, start triple antiretrovirals at 14 weeks' gestation and continue intrapartum and through childbirth. Stop if mother is not breastfeeding or continue until 1 week after all breastfeeding has stopped		Daily nevirapine or zidovudine from birth to 4–6 weeks
Option B+	All HIV-infected pregnant women start on triple antiretrovirals irrespective of CD4 cell count and continue for life		Daily nevirapine or zidovudine from birth to 4–6 weeks